UK markets closed

Vivesto AB (0N4A.L)

LSE - LSE Delayed price. Currency in SEK
Add to watchlist
1.3180-0.3530 (-21.13%)
At close: 03:06PM BST
Sign in to post a message.
  • L
    Léa
    The cyrpto market has been unstable. People ask themselves if this is the right time to invest? Are you a monetary patrons or newbies,searching for a real strategy to Invest and make grind benefit. Mr Jarvis Raymond signs, systems and capacities are wonderful. I have made more than $950K working with his sign and capacities with $60k theory. You can contact him on Telegm: @jartrade.
  • A
    Anonymous
    yes sir !
  • R
    Ron
    No other news or reason other than low float?
  • A
    Anonymous
    what a great ticker
  • B
    Brian
    in 1.55, out 2.75
  • S
    Suzy
    any predictions in near future?
  • s
    sam
    Positive news coming
  • O
    Orzy
    not a good salesman sam
  • B
    Brian
    looks like its about to skyrocket
  • j
    juliano
    new highs
  • R
    Ronald
    Sorry to say this but this was a pump and dump look at the chart, good luck to everyone but I honestly never seen something go to 3.50 plus and drops to almost 2 dollars with 5 minutes.....This will create so many bag-holders that might need to be here for a year to recover...
  • S
    Sam
    Exactly more buyers are pushing it up
  • A
    Anonymous
    on the train yeahhhhhhhhhh!!!!!
  • P
    Philip
    IM OUT!!!! TANK AWAY.>...
  • A
    Anonymous
    prepare to a big rally!
  • J
    John
    A buy rating what else making it jump ? A lot of interest
  • R
    Ron
    The ASCO Annual Meeting is an important opportunity to raise awareness of Oasmia in this forum where clinicians and other attendees are interested in the latest news regarding cancer treatment http://crweworld.com/article/news-provided-by-globenewswire/301307/results-from-oasmia-pharmaceuticals-phase-iii-study-will-be-presented-at-asco-annual-meeting-in-june
  • D
    Dennis
    PRESS RELEASE
    Oasmia Pharmaceutical Receives Positive CHMP Opinion for Apealea® (paclitaxel micellar) in the European Union
    Apealea receives positive CHMP opinion in the European Union for treatment of platinum-sensitive epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer in combination with carboplatin in first relapse

    https://prlibrary-eu.nasdaq.com/Resource/Download/8b01c01b-fc81-4350-9cfa-87c080ffbb5c
  • j
    juliano
    looking at this